EQIX
59
2
EQR
33
6
HOG
29
4
SLB
41
2
F
38
4
PX
56
3
MRK
25
2
AMP
43
2
DFS
64
4
ZTS
38
4
VMC
41
2
CTSH
55
3
MDLZ
28
2
DOV
48
2
EQT
47
13
AIG
38
5
MCO
67
3
XOM
33
3
GE
60
5
AZO
46
3
EQIX
59
2
EQR
33
6
HOG
29
4
SLB
41
2
F
38
4
PX
56
3
MRK
25
2
AMP
43
2
DFS
64
4
ZTS
38
4
VMC
41
2
CTSH
55
3
MDLZ
28
2
DOV
48
2
EQT
47
13
AIG
38
5
MCO
67
3
XOM
33
3
GE
60
5
AZO
46
3
Financhill
Back

Blueprint Medicines Vs. Vertex Pharmaceuticals Industry Stock Comparison

Sell
40

BPMC
Blueprint Medicines

Last Price:
$90.24
Seasonality Move:
2.18%
Sell
46

VRTX
Vertex Pharmaceuticals

Last Price:
$397.10
Seasonality Move:
6.89%
Sell
40
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $90.19. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Vertex Pharmaceuticals (VRTX) is a Sell

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $397.27. The Score for VRTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $90.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight buying pressure.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $397.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight buying pressure.

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 42.23 Sell
Chaikin Money Flow: 540770 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.73 - 96.57) Sell
Bollinger Bands (100): (87.46 - 96.54) Sell

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.99 Sell
Relative Strength Index (14 RSI): 24.09 Sell
Chaikin Money Flow: 2740027 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (437.81 - 475.91) Sell
Bollinger Bands (100): (455.22 - 489.42) Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.88 Sell
20-day SMA: 94.44 Sell
50-day SMA: 92.37 Sell
200-day SMA: 96.72 Sell
8-day EMA: 92.45 Sell
20-day EMA: 93.6 Sell
50-day EMA: 93.36 Sell
200-day EMA: 91.74 Sell

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 446.86 Sell
20-day SMA: 456.96 Sell
50-day SMA: 470.34 Sell
200-day SMA: 457.21 Sell
8-day EMA: 436.6 Sell
20-day EMA: 452.97 Sell
50-day EMA: 463.97 Sell
200-day EMA: 453.34 Sell

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.73 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.57 per share.

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.74 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.53 per share, and an increase next year of $18.29 per share.

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):